tirzepatide age approval Big update in pediatric diabetes care 🩺 Mounjaro® (tirzepatide) is now FDA- approved for children ≥10 years old with Type 2 diabetes as an adjunct to diet and exercise. What this means ⬇️ Weight-Loss Drugs: What's in Them

The Naranjo Adverse Drug Reaction Probability Scale yielded a score in the "possible" range for this case, suggesting a conceivable but not conclusively confirmed causal relationship (Table 2)

For post-GLP-1 patients who have already achieved significant fat loss, these treatments offer limited benefit and may actually accentuate loose skin by removing underlying volume

What Makes Tirzepatide Effective

These approaches can provide benefits beyond body weight alone: reducing GI side effects, micronutrient deficiencies, and muscle and bone loss, and improving general metabolic health and wellbeing

Local injection site reactions are not a medical reason to discontinue tirzepatide

At 1,500 calories per day with this ratio, your macros would look like this: Why the protein emphasis